| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3200293 | Journal of Allergy and Clinical Immunology | 2010 | 10 Pages |
Abstract
Long-term OIT appears to be safe and of some benefit in many patients with peanut allergy. With an increase in threshold levels and a reduction of peanut-specific TH2 cytokine production, the induction of tolerance may be feasible in some patients.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Katharina MD, Helen Ulbricht, Ute MD, Kerstin Dobberstein, John Beschorner, Lucila Camargo Lopes MD, Wayne G. MD, PhD, Hugh A. MD, Bodo MD, Ulrich MD, Kirsten MD,